- Report
- April 2023
- 113 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- August 2022
- 244 Pages
Global
From €7172EUR$7,500USD£6,146GBP
- Report
- July 2021
- 120 Pages
Global
From €4088EUR$4,275USD£3,503GBP
€4542EUR$4,750USD£3,892GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$3,921USD£3,104GBP
Ceftolozane is an antibiotic used to treat a variety of bacterial infections. It is a cephalosporin antibiotic, which works by inhibiting the growth of bacteria. Ceftolozane is often used in combination with tazobactam, an inhibitor of beta-lactamase enzymes, to increase its effectiveness. Ceftolozane is used to treat complicated intra-abdominal infections, complicated urinary tract infections, and hospital-acquired pneumonia. It is also used to treat infections caused by multidrug-resistant bacteria.
Ceftolozane is a relatively new antibiotic, and is not widely used. However, it is becoming increasingly popular due to its effectiveness against multidrug-resistant bacteria. It is also generally well-tolerated, with few side effects.
Some companies in the Ceftolozane market include Merck, Pfizer, AstraZeneca, and Allergan. Show Less Read more